Brief: Isofol Medical Q2 Loss For Period Widens To SEK 54.0 Million
Aug 23 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* ISOFOL MEDICAL AB (PUBL) PUBLISHES INTERIM REPORT,
JANUARY-JUNE
2022
* Q2 NET REVENUE AMOUNTED TO TSEK 4,027 (7,333) AND OTHER
REVENUE
TO TSEK 0 (0)
* Q2 RESULT FOR PERIOD AMOUNTED TO TSEK -54,033 (-45,394)
* Q2 EARNINGS PER SHARE AMOUNTED TO SEK -0.33 (-0.48)
Source text for Eikon: ID:nWkrbR9Zs3
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million
Brief: Isofol Medical Announces Bfarm Approval Of Optimized Phase Ib/Ii Study Design
Brief: Isofol Gets Gross Proceeds Of SEK 18.9 Mln In Connection With Exercise Of Warrants And Guarantee Commitments
Brief: Isofol Secures License Rights For Arfolitixorin In Autism